← Back to Search

Goals of Care Discussions for Advanced Lung and Gastrointestinal Cancer

N/A
Recruiting
Led By Ahmed Elsayem, MD,MPH
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant screens positive for at least 2 of 3 triple threat conditions (dyspnea, altered mental status, or poor performance status)
Participant has advanced lung or GI cancer defined as locally recurrent or metastatic with no curative treatment available
Must not have
Participant has baseline communication barriers such as aphasia or deafness
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to enhance the well-being of people with advanced cancer, provide assistance to their families, and reduce the overall expenses of their healthcare.

Who is the study for?
This trial is for patients with advanced lung or gastrointestinal cancer who visit the emergency department of a comprehensive cancer center. Specific eligibility criteria are not provided, but typically participants would need to meet certain health conditions.
What is being tested?
The study aims to compare two standard care approaches in the emergency setting: one focused on acute cancer care and another that includes discussions about goals of care, assessing their impact on quality of life and cost.
What are the potential side effects?
Since this trial compares different approaches to patient conversations and support rather than testing new medications, there are no direct side effects associated with medical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience shortness of breath, confusion, or am unable to perform daily activities.
Select...
My lung or GI cancer is advanced and cannot be cured with treatment.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have difficulty communicating due to conditions like aphasia or deafness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Goals of CareExperimental Treatment1 Intervention
In Group 2, participants will receive the above usual standard of care plus goals of care (GOC) intervention.
Group II: Acute Cancer Care CenterExperimental Treatment1 Intervention
In Group 1, participants will receive the usual standard of care, during your emergency room visit, provided by the Acute Cancer Care Center (ACCC) treating doctor who will address symptoms and other medical problems that brought the participant to the emergency room.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,059 Previous Clinical Trials
1,800,468 Total Patients Enrolled
Ahmed Elsayem, MD,MPHPrincipal InvestigatorM.D. Anderson Cancer Center
~133 spots leftby Feb 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top